The FDA has announced two added recalls of blood pressure medication tainted with a cancer-causing impurity.
Legacy Pharmaceutical Packaging, LLC issued a voluntary nationwide recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-
The United States Food and Drug Administration (FDA) has issued more recalls for the blood pressure medication losartan.
The latest recall notices were issued on Friday as two separate, voluntary recalls, both being issued in conjunction with Missouri-based Legacy Pharmaceuticals Packaging, LLC. No adverse effects related to these recalled hypertension drugs have been reported. Lists of the impacted lots of losaratan potassium tablets included in these latest recalls can be found here and here.
Starting in July, separate lots of ARB blood pressure and heart failure medications from various companies were recalled around the world, including in the United States, due to containing similar impurities that are potential or suspected human carcinogens. Here is the full list of recalled medications.
The FDA cautions that if you take any medications for hypertension, it is important not to discontinue use until you speak with your physician. Not taking blood pressure medication can be extremely dangerous, even if the risks associated with taking a medication tainted with a toxin also seem high.